Enantioselective Rhodium(I)-Catalyzed [3+2] Annulations of Aromatic Ketimines Induced by Directed CH Activations
Triple selectivity: Highly substituted indenylamines can be obtained with high enantioselectivity by formal [3+2] additions of aryl ketimines with internal alkynes. These rhodium(I)‐catalyzed processes proceed by selective CH activation of one of the two arene substituents, regioselective carbometa...
Saved in:
Published in | Angewandte Chemie International Edition Vol. 50; no. 47; pp. 11098 - 11102 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
18.11.2011
WILEY‐VCH Verlag Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Triple selectivity: Highly substituted indenylamines can be obtained with high enantioselectivity by formal [3+2] additions of aryl ketimines with internal alkynes. These rhodium(I)‐catalyzed processes proceed by selective CH activation of one of the two arene substituents, regioselective carbometalation of the alkyne, and enantioselective addition across the imine. |
---|---|
Bibliography: | ArticleID:ANIE201105766 EPFL istex:9B8E4DCC64C79298938877660F7778307135F844 European Research Council - No. 257891 ark:/67375/WNG-PFCFB4RC-Z We thank Dr. R. Scopelliti for X-ray crystallographic analysis of compound 7 m. This work was supported by the EPFL, ETH Zurich (ETH-16 08-3), and a starting grant from the European Research Council under the European Community's Seventh Framework Program (FP7 2007-2013)/ERC Grant agreement no. 257891. We thank Solvias AG for MeOBiphep ligands and Takasago International Corporation for Segphos ligands. ETH Zurich - No. ETH-16 08-3 We thank Dr. R. Scopelliti for X‐ray crystallographic analysis of compound This work was supported by the EPFL, ETH Zurich (ETH‐16 08‐3), and a starting grant from the European Research Council under the European Community’s Seventh Framework Program (FP7 2007–2013)/ERC Grant agreement no. 257891. We thank Solvias AG for MeOBiphep ligands and Takasago International Corporation for Segphos ligands. 7 m ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.201105766 |